Biovalis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 381,547 | 485,837 | 475,956 | 634,486 | 770,417 | 752,319 | 1,016,612 | 1,137,678 |
| Profit before tax | - | - | - | - | - | - | 14,342 | 9,825 |
| Net profit | -33,804 | 98,313 | 33,093 | 72,360 | 65,691 | 5,561 | 12,191 | 8,253 |
| Equity | 35,287 | 133,599 | 171,496 | 232,092 | 274,254 | 268,051 | 280,176 | 288,428 |
| Liabilities | 167,203 | 95,473 | 110,214 | 105,849 | 136,342 | 179,806 | 160,788 | 128,360 |
| Non-current assets | 109,546 | 117,057 | 147,957 | 136,583 | 189,079 | 157,576 | 125,035 | 173,188 |
| Current assets | 92,944 | 112,015 | 133,753 | 201,358 | 221,517 | 290,281 | 315,929 | 243,600 |
| Total assets | 202,490 | 229,072 | 281,710 | 337,941 | 410,596 | 447,857 | 440,964 | 416,788 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 24,120 | - | 52 |
| Social insurance contributions | - | - | - | - | - | 61,191 | 83,254 | 92,605 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +69.6% | +27.3% | -2.0% | +33.3% | +21.4% | -2.3% | +35.1% | +11.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -16.7% | 42.9% | 11.7% | 21.4% | 16.0% | 1.2% | 2.8% | 2.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -95.8% | 73.6% | 19.3% | 31.2% | 24.0% | 2.1% | 4.4% | 2.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -8.9% | 20.2% | 7.0% | 11.4% | 8.5% | 0.7% | 1.2% | 0.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 1.4% | 0.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.7 | 0.7 | 0.6 | 0.5 | 0.5 | 0.7 | 0.6 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 39,470 | 40,207 | 39,390 | 45,867 | 60,822 | 55,386 | 73,050 | 82,740 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biovalis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-04 | 2025-05-11 | 7.43 |
| 2025-04-24 | 2025-04-29 | 7.43 |
| 2025-02-18 | 2025-02-20 | 6882.05 |
| 2024-04-23 | 2024-05-14 | 11.88 |
| 2024-02-19 | 2024-02-21 | 5656.03 |
| 2021-11-09 | 2021-11-14 | 5.15 |
| 2021-09-16 | 2021-09-19 | 3430.40 |
Biovalis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-18 | 2026-03-18 | 5633.01 |
| 2026-02-21 | 2026-02-27 | 511.83 |
| 2026-01-27 | 2026-02-20 | 2.83 |
| 2026-01-16 | 2026-01-20 | 278.74 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biovalis, UAB (code 300535504) is a Private Limited Liability Company engaged in the construction of utility projects for fluids. In the latest financial year, 2025, the company generated revenue of €1.14M and net profit of €8.3K, corresponding to a profit margin of 0.7%. Revenue continued to grow year on year, rising by 11.9% from 2024 and by 51.2% over two years, from €752.3K in 2023 to €1.02M in 2024 and €1.14M in 2025. Profitability improved in 2024 before easing in 2025, when earnings remained positive but modest. The balance sheet remained stable, with total assets of €416.8K, equity of €288.4K and liabilities of €128.4K at year-end 2025. The equity ratio stood at 69.2% and debt-to-equity at 0.45, indicating a relatively strong capital structure. Asset turnover was 2.73x, ROE 2.9% and ROA 2.0%. The company also reported revenue per employee of €87.5K and profit per employee of €635, pointing to solid turnover generation with limited net profit retention.